Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

TELA Bio, Inc. - Common stock (NQ: TELA )

0.9596 -0.0124 (-1.28%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about TELA Bio, Inc. - Common stock

< Previous 1 2 3 4 5 Next >
Earnings Scheduled For March 21, 2022
Companies Reporting Before The Bell • Marinus Pharmaceuticals (NASDAQ:MRNS) is likely to report quarterly loss at $0.76 per share on revenue of $3.37 million. •... 
Via Benzinga
The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings
Biotech stocks rebounded along with the broader market in the week ending March 18, as risk appetite returned. Multiple conference presentations, clinical readouts and earnings news dictated sentiment... 
Via Benzinga
Preview: TELA Bio's Earnings
TELA Bio (NASDAQ:TELA) is set to give its latest quarterly earnings report on Monday, 2022-03-21. Here's what investors need to know before the announcement. Analysts estimate... 
Via Benzinga
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,... 
Via Benzinga
Exposures Product Safety
ROCE Insights For TELA Bio
In Q1, TELA Bio (NASDAQ:TELA) posted sales of $5.88 million. Earnings were up 7.74%, but TELA Bio still reported an overall loss of $7.27 million. In Q4, TELA Bio brought in $5.67... 
Via Benzinga
Insiders Buy Around $98M Of 3 Stocks
Although US stock futures traded lower this morning amid continued Russian bombing in Ukraine, there were a few notable insider trades. W... 
Via Benzinga
TELA Bio, Inc. (TELA) Q3 2021 Earnings Call Transcript
TELA earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
TELA Bio, Inc. (TELA) Q2 2021 Earnings Call Transcript
TELA earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
TELA Bio: Q2 Earnings Insights
Shares of TELA Bio (NASDAQ:TELA) decreased 2.3% after the company reported Q2 results. Quarterly Results Earnings per share decreased 7.55% over the past year to ($0.57), which... 
Via Benzinga
Earnings Outlook For TELA Bio
On Wednesday, August 11, TELA Bio (NASDAQ:TELA) will report its last quarter's earnings. Here is Benzinga's preview of the company's release. Net Income, Earnings, And Earnings... 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers RAPT Therapeutics (NASDAQ:RAPT) s... 
Via Benzinga
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (... 
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,... 
Via Benzinga
Exposures Product Safety
Earnings Scheduled For August 11, 2021
Companies Reporting Before The Bell • Wireless Telecom Group (AMEX:WTT) is likely to report earnings for its second quarter. • Gamida Cell (NASDAQ:GMDA) is... 
Via Benzinga
TELA Bio Launches Post Market Study Of OviTex In Hernia Surgery
TELA Bio Inc (NASDAQ: TELA) has launched its second post-market study, BRAVO II, to evaluate the clinical performance of OviTex Reinforced Tissue Matrices in the... 
Via Benzinga
TELA Bio, Inc. (TELA) Q1 2021 Earnings Call Transcript
TELA earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
TELA Bio: Q1 Earnings Insights
Shares of TELA Bio (NASDAQ:TELA) rose in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 11.11% year over year to ($0.56... 
Via Benzinga
TELA Bio Inc. (TELA) Q4 2020 Earnings Call Transcript
TELA earnings call for the period ending December 31, 2020. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Earnings Scheduled For May 13, 2021
Companies Reporting Before The Bell • CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report quarterly loss at $0.06 per share on revenue of $5.05 million. •... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.